ASACOLON Gastro-resistant tablet Ref.[50879] Active ingredients: Mesalazine

Source: Health Products Regulatory Authority (IE)  Revision Year: 2023  Publisher: Tillotts Pharma GmbH, Warmbacher Strasse 80, DE- 79618 Rheinfelden, Germany

4.1. Therapeutic indications

Asacolon is indicated in adults, children above 6 years and adolescents:

For the treatment of mild to moderate acute ulcerative colitis. For the maintenance of remission of ulcerative colitis.

For the maintenance of surgically-induced remission of Crohn’s Disease.

4.2. Posology and method of administration

Posology

Adults

Ulcerative colitis

Induction of remission: 2.4 g (3 tablets) per day once daily or in divided doses. If required the dose may be increased to 4.8 g (6 tablets) per day in divided doses. Above 2.4 g daily in divided doses only. The dosage can be adjusted in accordance with the response to the treatment.

Maintenance of remission: 1.6 to 2.4 g (2 to 3 tablets) per day once daily or in divided doses.

Crohn’s disease

Maintenance of remission: 2.4 g (3 tablets) per day once daily or in divided doses.

Older people

The normal adult dose can be taken unless liver or renal function is severely impaired (see section 4.3 and 4.4). No studies have been carried out in older people.

Paediatric population

There is only limited documentation for an effect in children (age 6-18 years).

Children 6 years of age and older

  • Active disease: To be determined individually, starting with 30-50 mg/kg/day in divided doses. Maximum dose: 75 mg/kg/day in divided doses. The total dose should not exceed 4.0 g/day.
  • Maintenance treatment: To be determined individually, starting with 15-30 mg/kg/day in divided doses. The total dose should not exceed 2.0 g/day.

Method of administration

Oral.

The tablets must be swallowed whole preferably with some liquid before food intake.

They must not be chewed, crushed or broken before swallowing.

If one or more doses have been missed, the next dose is to be taken as usual.

4.9. Overdose

There is little data on overdose (e.g. intended suicide with high oral doses of mesalazine), which do not indicate renal or hepatic toxicity. There is no specific antidote and treatment is symptomatic and supportive.

6.3. Shelf life

3 years.

6.4. Special precautions for storage

Do not store above 25ยบC.

Store in the original package in order to protect from moisture.

6.5. Nature and contents of container

Blister strips of aluminium foil and PVC, and outer cardboard carton containing 90 tablets per pack.

6.6. Special precautions for disposal and other handling

No special requirements. Any unused medicinal product or waste material should be disposed of in accordance with local requirements.

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.